Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis

BACKGROUND: The prognostic role of pretreatment modified Glasgow Prognostic Score (mGPS) in small cell lung cancer (SCLC) patients remains unclear now. METHODS: The PubMed, EMBASE, Web of Science, and CNKI electronic databases were searched up to December 14, 2022. The primary and secondary outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yulian, Li, Hongjun, Hu, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637526/
https://www.ncbi.nlm.nih.gov/pubmed/37960803
http://dx.doi.org/10.1097/MD.0000000000035962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637526/
https://www.ncbi.nlm.nih.gov/pubmed/37960803
http://dx.doi.org/10.1097/MD.0000000000035962

Ejemplares similares